Interferon alfa-2c and proteinuria in a patient with focal and segmental glomerulosclerosis

Ritanserin improves sleep quality in narcolepsy.

Pharmacopsychiatry·2003

A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*).

Endoscopy·2003

Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.

Pharmacogenomics·2003

Study of a patient population investigated for excessive daytime sleepiness (EDS).

Neurophysiologie clinique = Clinical neurophysiology·2003

HLA and genetic susceptibility to sleepwalking.

Molecular psychiatry·2003

[Ultrasonic diagnosis of calciphylactic lesions].

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2003

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Lancet (London, England)·2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Journal of cutaneous medicine and surgery·2026

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Drugs in context·2026

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

iScience·2026

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

Materials today. Bio·2026

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

Frontiers in immunology·2026

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Drugs in context·2026

Related Experiment Videos

Interferon alfa-2c and proteinuria in a patient with focal and segmental glomerulosclerosis

Related Concept Videos

Ritanserin improves sleep quality in narcolepsy.

A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*).

Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.

Study of a patient population investigated for excessive daytime sleepiness (EDS).

HLA and genetic susceptibility to sleepwalking.

[Ultrasonic diagnosis of calciphylactic lesions].

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Related Experiment Videos

Interferon alfa-2c and proteinuria in a patient with focal and segmental glomerulosclerosis

Related Concept Videos

Related Articles